Loading...
DOCUMENTS
21
NOTICES
32
MOTS CLES
Inflammatory bowel diseases
Fecal microbiota
MALT
Monitoring
Algorithm
Cancer
Crohn’s disease
Thérapie ciblée
Patient-reported outcome
Immunosuppressant
Gene expression
MORTALITY
Vedolizumab
Intestinal crypts
Disability
Biologics
Colectomy
Gènes
Genes
Microbiote
Drug
DNA methylation
Résistance
Cost effectiveness
HIV
Alkylating agents
Primary sclerosing cholangitis
Epigénétiques
MARKER
Inflammatory Bowel Diseases
Bacteria
IBD
Inclusion
Survival
Ulcerative colitis
Dysbiosis
Rituximab plus chlorambucil
Colon
Anti-TNF
Over 80s
Disease progression
IL12
Acceptability
Heart disease risk factors
Methylation
MICROBIOTA
Anti-TNF agents
Neoadjuvant chemotherapy
IL23
Inhibitor
Gene methylation
Disease Progression
Maintenance therapy
Rituximab
Tuberculosis
Resistance
Parvimonas micra
Endoscopic treatment
Therapeutics
Eligibility
Safety
Effectiveness
Colorectal cancer
Small molecules
Crohn's disease
DNA METHYLATION
Original Article Clinical
Clinical guidelines
Venous thromboembolism
Microbiota
Kidney diseases
CARCINOGENESIS
Colorectal cancer Colibactin and lipids
Consensus
Clinical trial
Colon cancer
PCR
Screening
Méthylation
COLON-CANCER
Cell adhesion
Stricture
Inflammatory bowel disease
RISK
Surgery
Biomarker
Ustekinumab
Upper gastrointestinal tract
18 FDG-PET/CT
Tailored therapy
Immune cells
T1118 translocation
Patients experience
Bactéries
Colonic epithelial primary cells
Helicobacter pylori
Eradication
Epigenetics
Dysbiose
Contraindication
Early detection of Colon Cancer using Molecular Markers and Microbiota , EA 7375 | |
---|---|
Institutions |
UPEC |
Adresse |
Université Paris-Est Créteil Groupe Hospitalier Henri Mondor Service de Gastroentérologie 51 Av Maréchal de Lattre de Tassigny 94010 Créteil cedex |
Courriel |
|
Site Internet |
|
Rattachement(s) |
|
Direction |
Aurélien AMIOT |
Adjoint |
Iradj SOBHANI |
Axe(s) de recherche
|
Le laboratoire axe ses recherches sur le rôle du microbiome intestinal ainsi que des changements épigénétiques dans l'intestin afin :
|
Derniers dépôts
-
Lucas Guillo, Mathieu Uzzan, Laurent Beaugerie, Jean-Marc Gornet, Aurélien Amiot, et al.. Impact of HIV Infection on the Course of Inflammatory Bowel Disease and Drug Safety Profile: A Multicenter GETAID Study. Clinical Gastroenterology and Hepatology, 2022, 20 (4), pp.787-797.e2. ⟨10.1016/j.cgh.2020.12.023⟩. ⟨hal-04168380⟩
-
Iradj Sobhani, Emma Bergsten, Cecile Charpy, Mathias Chamaillard, Denis Mestivier. Virulent Bacteria as Inflammatory and Immune Co-Factor in Colon Carcinogenesis: Evidence From Two Monozygotic Patients and Validation in CRC Patient and Healthy Cohorts. Frontiers in Cellular and Infection Microbiology, 2021, 11, pp.749750. ⟨10.3389/fcimb.2021.749750⟩. ⟨hal-04543208⟩
-
Lucas Guillo, Guillaume Savoye, Aurélien Amiot, Cyrielle Gilletta, Maria Nachury, et al.. Prevalence of and factors associated with extraintestinal manifestations and their remission in inflammatory bowel disease: the EXTRA prospective study from the GETAID. Clinical and translational gastroenterology, 2023, 14 (12), pp.e00607. ⟨10.14309/ctg.0000000000000607⟩. ⟨hal-04206330⟩
-
Florence Canouï-Poitrine, Astrid Lièvre, Florent Dayde, Daniel Lopez-Trabada-Ataz, Isabelle Baumgaertner, et al.. Inclusion of Older Patients with Cancer in Clinical Trials: The SAGE Prospective Multicenter Cohort Survey. Oncologist, 2019, 24 (12), pp.e1351-e1359. ⟨10.1634/theoncologist.2019-0166⟩. ⟨hal-04126614⟩
-
Maria Nachury, Yoram Bouhnik, Mélanie Serrero, Jerome Filippi, Xavier Roblin, et al.. Patients’ real-world experience with inflammatory bowel disease: A cross-sectional survey in tertiary care centres from the GETAID group. Digestive and Liver Disease, 2021, 53 (4), pp.434-441. ⟨10.1016/j.dld.2020.10.020⟩. ⟨hal-03038260⟩
-
Julien Tap, Aurélien Amiot, Véronique Jarrousse, Sandra Guilmeau, Jeanne Tran Vannhieu, et al.. Early Phenotypical Changes Induced By Transfer Of Human Fecal Microbiota from Colorectal Cancer Patients To Germ-Free Mice. International Journal of Cancer and Oncology, 2017, 4 (1), pp. 1-11. ⟨10.15436/2377-0902.16.1128⟩. ⟨hal-03825702⟩
-
Nicolas Petitdidier, Laurent Beaugerie, Franck Carbonnel, Anne Bourrier, Xavier Treton, et al.. Real-world use of therapeutic drug monitoring of CT-P13 in patients with inflammatory bowel disease: A 12-month prospective observational cohort study. Clinics and Research in Hepatology and Gastroenterology, 2020, 44, pp.609 - 618. ⟨10.1016/j.clinre.2019.11.008⟩. ⟨hal-03492351⟩